Under what circumstances would you consider outpatient induction for AML?

At some centers, I know that induction with venetoclax and azacytidine/decitabine/low dose cytarabine or liposomal cytarabine/daunorubicin (CPX-351) for patients with newly diagnosed AML has been administered in the outpatient setting. However, in these centers (such as Moffitt Cancer Center), there needs to be availability of staff and resources to see patients on a DAILY basis, check labs, and administer IVF (for tumor lysis) and daily transfusions. Such centers have clinicians available, typi...